{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:54Z","timestamp":1791328914315,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1124\/mol.104.010710","type":"journal-article","created":{"date-parts":[[2005,2,17]],"date-time":"2005-02-17T01:33:28Z","timestamp":1108604008000},"page":"1714-1722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor"],"prefix":"10.1016","volume":"67","author":[{"given":"J\u00e9r\u00f4me","family":"Fagart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cendrine","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory Maurice","family":"Pinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Edith","family":"Rafestin-Oblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.104.010710_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.104.010710_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0026-895X(24)23099-6","article-title":"A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11\u03b2-substituted spirolactones","volume":"58","author":"Auzou","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.104.010710_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"key":"10.1124\/mol.104.010710_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0960-0760(03)00036-0","article-title":"Glucocorticoid metabolism by 11-beta hydroxysteroid dehydrogenase type 2 modulates human mineralocorticoid receptor transactivation activity","volume":"84","author":"Bocchi","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/mol.104.010710_bib5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/prep.2000.1248","article-title":"Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization and preliminary X-ray diffraction analysis","volume":"19","author":"Bourguet","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1124\/mol.104.010710_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.104.010710_bib7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/endo-104-4-1194","article-title":"Mechanism of action of a new antialdosterone compound, prorenone","volume":"104","author":"Claire","year":"1979","journal-title":"Endocrinology"},{"key":"10.1124\/mol.104.010710_bib8","first-page":"199","article-title":"Spirolactones: clinical and pharmacologic studies","volume":"7","author":"Corvol","year":"1978","journal-title":"Adv Nephrol Necker Hosp"},{"key":"10.1124\/mol.104.010710_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj3150421","article-title":"Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure","volume":"315","author":"Couette","year":"1996","journal-title":"Biochem J"},{"key":"10.1124\/mol.104.010710_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1210\/mend.12.6.0119","article-title":"Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor","volume":"12","author":"Couette","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib11","first-page":"725","article-title":"Firefly luciferase gene: structure and expression in mammalian cells","volume":"7","author":"de Wet","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.104.010710_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","article-title":"The steroid and thyroid hormone receptor superfamily","volume":"240","author":"Evans","year":"1988","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.104.010710_bib13","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.104.010710_bib14","first-page":"F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.104.010710_bib15","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1073\/pnas.95.6.2973","article-title":"Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists","volume":"95","author":"Fejes-Toth","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.104.010710_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1210\/mend.14.6.0467","article-title":"Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1)","volume":"14","author":"Fuse","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib17","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1210\/jcem.80.12.8530580","article-title":"Primary aldosteronism (Conn\u2019s syndrome)","volume":"80","author":"Gittler","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/mol.104.010710_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/mol.104.010710_bib19","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/nar\/19.7.1563","article-title":"Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter","volume":"19","author":"Gouilleux","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.104.010710_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/mend.14.8.0502","article-title":"Crucial role of the H11\u2013H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor","volume":"14","author":"Hellal-Levy","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0092-8674(84)90472-0","article-title":"Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma","volume":"39","author":"Herbomel","year":"1984","journal-title":"Cell"},{"key":"10.1124\/mol.104.010710_bib22","first-page":"1399","article-title":"Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface","volume":"10","author":"Liu","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1124\/mol.104.010710_bib24","doi-asserted-by":"crossref","first-page":"26164","DOI":"10.1074\/jbc.M004571200","article-title":"Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations","volume":"275","author":"Matias","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.010710_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2174\/1381612033455053","article-title":"Eplerenone, a new selective aldosterone blocker","volume":"9","author":"McMahon","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1124\/mol.104.010710_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"10.1124\/mol.104.010710_bib27","first-page":"1152","article-title":"A single amino acid substitution (Met786\u2014Val) in the steroid-binding domain of human androgen receptor leads to complete androgen insensitivity syndrome","volume":"74","author":"Nakao","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/mol.104.010710_bib28","first-page":"769","article-title":"Dual roles of 90-kDa heat shock protein in the function of the mineralocorticoid receptor","volume":"113","author":"Nemoto","year":"1993","journal-title":"J Biochem (Tokyo)"},{"key":"10.1124\/mol.104.010710_bib29","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.104.010710_bib30","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.104.010710_bib31","first-page":"306","article-title":"Steroid receptor interactions with heat shock protein and immunophilin chaperones","volume":"18","author":"Pratt","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1124\/mol.104.010710_bib32","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1016\/S0021-9258(18)60531-9","article-title":"Mineralocorticosteroid receptor of the chick intestine. Oligomeric structure and transformation","volume":"264","author":"Rafestin-Oblin","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.104.010710_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00413-6","article-title":"Interdomain interactions in the mineralocorticoid receptor","volume":"200","author":"Rogerson","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.104.010710_bib34","first-page":"597","article-title":"Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor","volume":"7","author":"Rupprecht","year":"1993","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib35","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/me.2003-0299","article-title":"Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification","volume":"17","author":"Tallec","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.104.010710_bib36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1995.2464","article-title":"Ligand-induced conformational changes in the mineralocorticoid receptor analyzed by protease mapping","volume":"215","author":"Trapp","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.104.010710_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1124\/mol.104.010710_bib38","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/30775","article-title":"Atomic structure of progesterone complexed with its receptor","volume":"393","author":"Williams","year":"1998","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.104.010710_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nsb0196-87","article-title":"A canonical structure for the ligand-binding domain of nuclear receptors","volume":"3","author":"Wurtz","year":"1996","journal-title":"Nat Struct Biol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24067506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.104.010710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:05:10Z","timestamp":1740042310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24067506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0026895X24067506"],"URL":"https:\/\/doi.org\/10.1124\/mol.104.010710","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Met852 Residue Is a Key Organizer of the Ligand-Binding Cavity of the Human Mineralocorticoid Receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.104.010710","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}